Details for New Drug Application (NDA): 083176
✉ Email this page to a colleague
NDA 083176 describes REMSED, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the REMSED profile page.
The generic ingredient in REMSED is promethazine hydrochloride. There are twelve drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
The generic ingredient in REMSED is promethazine hydrochloride. There are twelve drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
Summary for 083176
| Tradename: | REMSED |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | promethazine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 083176
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
